2015·University of Zambia
Atazanavir-ritonavir (ATV-r) has been recommended by the World Health Organization as part of second-line combination antiretroviral therapy (cART) in HIV-infected patients aged 6 years and above. In 2013, the Zambia HIV treatment program introduced ATV-ras an alternative Protease Inhibitor (PI)...
Download PDF ↓